Trial Scout

A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain

Study Location

OBGYN Associates of WNY

ClinicalTrials.gov Identifier: NCT03213457
Recruitment Status: Recruiting
First Posted: 7/11/2017 12:00:00 AM
Last Update Posted: 3/15/2019 12:00:00 AM

Study Description

Eligibility Criteria

Additional Contacts

Brief Summary

A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination With Estradiol/Norethindrone Acetate in Subjects With Moderate to Severe Endometriosis-Associated Pain

Condition or Disease

Endometriosis

Intervention/Treatment

Other: Placebo for Elagolix / Tablet

Phase

Phase 3

Detailed Description

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Go to ClinicalTrials.gov >